Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
trial crawled date : 2021 - 09 - 08 save search
Worldwide Industrial Controls Industry to 2030 - Featuring Siemens, Honeywell International and Emerson Electric Among Others
Published: 2021-09-08 (Crawled : 22:00) - prnewswire.com
GIC | $40.96 -0.82% 0.0% 57K
|
Retail Trade
|
| O: -0.6%
H: 1.67%
C: 0.61%
EMR | $109.62 -0.14% -1.93% 1.9M
|
Producer Manufacturing
|
| O: 0.21%
H: 0.0%
C: -3.14%
DOV | $171.44 -0.49% 0.0% 1.3M
|
Producer Manufacturing
|
| O: 0.09%
H: 0.83%
C: -0.09%
ABB | News | $37.13 -0.03% 6.4M
|
Producer Manufacturing
|
| O: 0.41%
H: 0.49%
C: -0.41%
trial
Aptiv to Present at the RBC Capital Markets Global Industrials Conference
Published: 2021-09-08 (Crawled : 21:00) - prnewswire.com
APTV | $71.4 1.64% 1.33% 1.9M
|
Producer Manufacturing
|
| O: -0.24%
H: 1.04%
C: 0.85%
trials trial conference
Cardiff Oncology Announces New Data from Phase 1b/2 Trial in KRAS-mutated Metastatic Colorectal Cancer Showing Robust Objective Response Rate and Progression Free Survival
Published: 2021-09-08 (Crawled : 21:00) - biospace.com/
CRDF | $4.16 -0.24% -0.24% 340K
|
Health Services
|
| O: 0.0%
H: 1.49%
C: -4.6%
phase 1 cancer colorectal cancer trial phase 1b phase 2b
STAG Industrial To Participate In Three Industry Conferences
Published: 2021-09-08 (Crawled : 20:00) - prnewswire.com
STAG | $34.75 -1.86% 0.0% 1.6M
|
Finance
|
| O: -0.02%
H: 0.23%
C: -2.23%
trial conference
Inventiva announces the initiation of its pivotal Phase III clinical trial evaluating lanifibranor in NASH
Published: 2021-09-08 (Crawled : 20:00) - inventivapharma.com
IVA | $3.28 -0.3% -0.3% 13K
|
Health Technology
|
| O: -0.87%
H: 2.64%
C: 1.25%
nash trial
A functional magnetic resonance imaging investigation of prefrontal cortex deep transcranial magnetic stimulation efficacy in adults with attention deficit/hyperactive disorder: A double blind, randomized clinical trial
Published: 2021-09-08 (Crawled : 14:15) - brainsway.com
BWAY | $5.03 1.93% 1.89% 26K
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: -1.6%
magnetic resonance trial imaging
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability
Published: 2021-09-08 (Crawled : 14:00) - igcinc.us
IGC 4 | $0.439 -3.86% 1.78% 430K
|
Health Technology
|
| O: 6.92%
H: 1.76%
C: -7.06%
alzheimer phase 1 trial phase 2 phase 3 alzheimer’s alzheimer's
Daxor Corporation To Present Compelling New Data and Clinical Trials Utilizing the BVA-100® Blood Test at the Heart Failure Society of America Annual Scientific Meeting 2021
Published: 2021-09-08 (Crawled : 14:00) - daxor.com
DXR | $9.8 0.73% 910
|
Health Technology
|
| O: -2.52%
H: 6.29%
C: 2.78%
blood heart clinical trials test trials trial
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $10.0 Million Regulatory Milestone Phase 2 Clinical Trial to Evaluate NBI-921352 for the Treatment of Focal-Onset Seizures in Adults Anticipated in 2021
Published: 2021-09-08 (Crawled : 14:00) - biospace.com/
XENE | $39.46 -3.97% -4.13% 330K
|
Health Technology
|
| O: 0.06%
H: 1.98%
C: -2.94%
NBIX | News 4 | $138.91 -0.84% -0.85% 880K
|
Health Technology
|
| O: -0.62%
H: 1.8%
C: 1.72%
treatment phase 2 collaboration announces collaboration trial milestone
Repetitive Transcranial Magnetic Stimulation for Smoking Cessation: a Pivotal Multicenter Double-Blind Randomized Controlled Trial
Published: 2021-09-08 (Crawled : 13:00) - brainsway.com
BWAY | $5.03 1.93% 1.89% 26K
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: -1.6%
trial
Novavax Initiates Phase 1/2 Clinical Trial of Combination Vaccine for COVID-19 and Seasonal Influenza
Published: 2021-09-08 (Crawled : 13:00) - biospace.com/
NVAX | $4.15 -0.96% -0.96% 2.4M
|
Health Technology
|
| O: 0.92%
H: 1.74%
C: -2.29%
covid phase 1 vaccine influenza trial phase 2 phase 3 covid-19
Benitec Biopharma Provides Positive Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
Published: 2021-09-08 (Crawled : 12:00) - ir.benitec.com
BNTC | $6.75 -1.6% -1.63% 66K
|
Health Technology
|
| O: -1.53%
H: 2.34%
C: -1.82%
bb-301 biopharma phase 1 positive trial phase 1b phase 2b
Benitec Biopharma Provides Overview of the BB-301 Phase 1b/2a Clinical Trial Design for 2022
Published: 2021-09-08 (Crawled : 12:00) - ir.benitec.com
BNTC | $6.75 -1.6% -1.63% 66K
|
Health Technology
|
| O: -1.53%
H: 2.34%
C: -1.82%
bb-301 biopharma phase 1 trial phase 1b phase 2b designation
Hoth Therapeutics Announces Positive Phase 1b Results for Completed First Cohort of Patient Trial of BioLexa
Published: 2021-09-08 (Crawled : 12:00) - ir.hoththerapeutics.com
HOTH | $1.19 1.2% 17K
|
Health Technology
|
| O: -1.49%
H: 1.52%
C: 1.52%
phase 1 positive results trial phase 1b phase 2b
Galera Announces Final Results from Pancreatic Cancer Trial Showing Improvements on all Efficacy Parameters
Published: 2021-09-08 (Crawled : 12:00) - biospace.com/
GRTX | $0.1821 -6.13% -6.53% 810K
|
Health Technology
|
| O: 2.18%
H: 3.88%
C: -4.89%
results cancer trial pancreatic pancreas
Longboard Pharmaceuticals Successfully Completes LP352 Multiple Ascending Dose Portion of Phase 1 Clinical Trial in Healthy Volunteers, Plans to Initiate Phase 1b/2a Clinical Trial
Published: 2021-09-08 (Crawled : 12:00) - biospace.com/
LBPH | $19.76 -2.52% -2.58% 300K
|
Manufacturing
|
| O: -0.58%
H: 1.75%
C: 1.55%
phase 1 trial phase 1b phase 2b
Calithera Biosciences to Present Telaglenastat KEAPSAKE Trial in Progress Poster at the IASLC 2021 World Conference on Lung Cancer
Published: 2021-09-08 (Crawled : 12:00) - biospace.com/
CALA | $0.029 150.0% 580
|
Health Technology
|
| O: -0.87%
H: 3.51%
C: 3.07%
lung cancer cancer trial conference
HUTCHMED and AstraZeneca Initiate SANOVO Phase III Trial of ORPATHYS® and TAGRISSO® Combination as a First-Line Therapy for Certain Lung Cancer Patients in China
Published: 2021-09-08 (Crawled : 11:00) - globenewswire.com
HCM | $18.405 0.85% 0.84% 58K
|
Health Technology
|
| O: -2.29%
H: 1.34%
C: 1.29%
AZN | News | $71.175 0.46% 0.46% 6.1M
|
Health Technology
|
| O: -1.85%
H: 0.17%
C: -0.42%
lung cancer china therapy cancer trial
ISA Pharmaceuticals Commences Patient Treatment in Third Phase 2 Clinical Trial with the Combination of ISA101b and Libtayo® (cemiplimab)
Published: 2021-09-08 (Crawled : 08:00) - prnewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: -2.48%
H: 0.16%
C: -0.32%
treatment phase 2 trial
Innovent Announces First Patient with Type 2 Diabetes Dosed in a Phase 2 Clinical Trial of IBI362 (a GLP-1R and Glucagon Receptor Dual Agonist) in China
Published: 2021-09-08 (Crawled : 00:00) - prnewswire.com
LLY | News | $732.2 -1.81% 0.18% 2.1M
|
Health Technology
|
| O: -0.08%
H: 0.44%
C: 0.09%
diabetes phase 2 china trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.